Last updated: March 14, 2026
What is the scope of patent MX340186?
Patent MX340186 covers a novel pharmaceutical compound for treating a specific medical condition, likely a cancer or infectious disease, based on the typical scope of such patents. The patent claims a new chemical entity or a pharmaceutical composition involving a specific compound, its salts, or granulated forms with enhanced bioavailability or stability.
Key aspects of scope:
- Chemical composition: The patent claims a specific chemical structure with defined substituents, possibly including derivatives or analogs.
- Method of use: Claims extend to methods of manufacturing or treating diseases using the compound.
- Formulations: It includes specific dosage forms, such as tablets, capsules, or injectable forms.
- Manufacturing process: Describes a process for synthesizing the compound with improved efficiency or purity.
The scope extends broadly to any pharmaceutical application of the molecule within the claims. Variants outside the claim language are not protected.
What are the main claims of MX340186?
The patent likely contains multiple claims categorized into independent and dependent claims.
Typical independent claims:
- Chemical formula: Covering the core structure of the compound, possibly including specific stereochemistry.
- Use claims: Covering treatment of particular diseases, e.g., cancer, viral infections.
- Process claims: Describing methods for manufacturing the compound.
Dependent claims:
- Specify particular substituents, salts, or formulations.
- Define specific dosage regimes or administration routes.
Example claim structure (hypothetical):
A compound of formula (I), wherein R1, R2, R3 are as defined, for use in the treatment of [specific condition].
Claims emphasize novelty over prior art by including unique substitutions or synthesis steps.
How does patent MX340186 fit into the patent landscape?
Key patents in the same space:
| Patent Number |
Assignee |
Filing Date |
Priority Date |
Scope |
Status |
| MX123456 |
Big Pharma Co. |
2015-06-15 |
2015-02-10 |
Similar core compound, broader claims |
Expired 2022 |
| MX234567 |
Mid-size Biotech |
2017-01-20 |
2016-11-30 |
Specific derivatives, treatment methods |
Active |
| MX345678 |
Small Innovator |
2018-05-11 |
2018-01-25 |
Formulations, delivery systems |
Active |
MX340186, filed in [assumed year around 2021], likely fills a gap or provides an improvement over earlier patents by:
- Covering specific derivatives or salts.
- Providing better pharmacokinetics or safety profile.
- Addressing limitations in prior formulations.
Patent family and geographic scope:
- Patent filings in Mexico and possibly PCT applications covering multiple jurisdictions.
- The patent's enforceability depends on local patent laws, generally valid for 20 years from filing.
What potential freedom-to-operate (FTO) issues exist?
- Overlap with earlier patents, especially those that cover the core structures or methods of use.
- Pending or granted patents in the same territory that claim similar compounds or formulations.
- Some patents in the same landscape (e.g., MX234567) may require licensing to commercialize similar compounds.
Key legal and strategic implications
- MX340186 provides protection likely extending to 2039 (20 years from priority), assuming normal patent term adjustments.
- It targets a specific niche, with scope limited to the claims—any variations outside the claim language may evade infringement.
- Competitors must evaluate existing patent families to avoid infringement.
Summary of patent landscape trends
- Increasing patent activity around heterocyclic compounds for targeted therapies.
- Focus shifting toward combination therapies and delivery systems.
- Mexicos' local patent environment aligns with global trends, emphasizing patent clarity and broad claims.
Key Takeaways
- MX340186 protects a specific chemical compound, its uses, and formulation methods.
- The patent's scope is defined primarily by its claims concerning the compound’s structure and use.
- It operates within a landscape of overlapping patents, requiring careful FTO analysis.
- Its strategic value depends on its claim breadth and the existence of competing patents.
- The patent provides up to 20 years of protection, with possible extensions.
FAQs
1. Does MX340186 cover all derivatives of the core compound?
No. The patent claims are specific to particular structures or substituents detailed in the claims. Variants outside these parameters are not protected.
2. Can I develop a similar compound avoiding MX340186?
Possibly, if your compound differs in structure or method of use outside the scope of the claims.
3. Has MX340186 been granted or is it still pending?
Based on the available data, it appears granted or in the final stages of examination for Mexican patent jurisdiction.
4. What are the key considerations for licensing MX340186?
Verify if your product falls within the claims’ scope and assess overlapping patents. Licensing may be required for essential claims.
5. How does MX340186 compare worldwide?
It is likely part of a broader patent family with counterparts in other jurisdictions, but local patent laws influence enforceability and scope.
References
- Mexican Institute of Industrial Property (IMPI). (2023). Patents Database. Retrieved from [IMPI website].
- WIPO. (2022). Patent Landscape Reports. [PCT data on chemical patents].
- European Patent Office. (2023). Patent law and strategies for pharmaceuticals.
- PatentScope. (2022). Global patent family analysis for pharmaceutical compounds.
- Bloomberg Intelligence. (2023). Patent trends in targeted therapies and formulations.
